Activation of BRCA1/BRCA2-Associated helicase BACH1 is required for timely progression through S phase

被引:86
作者
Kumaraswamy, Easwari [1 ]
Shiekhattar, Ramin [1 ]
机构
[1] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA
关键词
D O I
10.1128/MCB.00961-07
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BACH1 (also known as FANCJ and BRIP1) is a DNA helicase that directly interacts with the C-terminal BRCT repeat of the breast cancer susceptibility protein BRCA1. Previous biochemical and functional analyses have suggested a role for the BACH1 homolog in Caenorhabditis elegans during DNA replication. Here, we report the association of BACH1 with a distinct BRCA1/BRCA2-containing complex during the S phase of the cell cycle. Depletion of BACH1 or BRCA1 using small interfering RNAs results in delayed entry into the S phase of the cell cycle. Such timely progression through S phase requires the helicase activity of BACH1. Importantly, cells expressing a dominant negative mutation in BACH1 that results in a defective helicase displayed increased activation of DNA damage checkpoints and genomic instability. BACH1 helicase is silenced during the G(1) phase of the cell cycle and is activated through a dephosphorylation event as cells enter S phase. These results point to a critical role for BACH1 helicase activity not only in the timely progression through the S phase but also in maintaining genomic stability.
引用
收藏
页码:6733 / 6741
页数:9
相关论文
共 44 条
[21]   Chromatin association of human origin recognition complex, Cdc6, and minichromosome maintenance proteins during the cell cycle:: Assembly of prereplication complexes in late mitosis [J].
Méndez, J ;
Stillman, B .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (22) :8602-8612
[22]   SUVi and BACH1: a new subfamily of mammalian helicases? [J].
Menichini, P ;
Linial, M .
MUTATION RESEARCH-DNA REPAIR, 2001, 487 (1-2) :67-71
[23]   A STRONG CANDIDATE FOR THE BREAST AND OVARIAN-CANCER SUSCEPTIBILITY GENE BRCA1 [J].
MIKI, Y ;
SWENSEN, J ;
SHATTUCKEIDENS, D ;
FUTREAL, PA ;
HARSHMAN, K ;
TAVTIGIAN, S ;
LIU, QY ;
COCHRAN, C ;
BENNETT, LM ;
DING, W ;
BELL, R ;
ROSENTHAL, J ;
HUSSEY, C ;
TRAN, T ;
MCCLURE, M ;
FRYE, C ;
HATTIER, T ;
PHELPS, R ;
HAUGENSTRANO, A ;
KATCHER, H ;
YAKUMO, K ;
GHOLAMI, Z ;
SHAFFER, D ;
STONE, S ;
BAYER, S ;
WRAY, C ;
BOGDEN, R ;
DAYANANTH, P ;
WARD, J ;
TONIN, P ;
NAROD, S ;
BRISTOW, PK ;
NORRIS, FH ;
HELVERING, L ;
MORRISON, P ;
ROSTECK, P ;
LAI, M ;
BARRETT, JC ;
LEWIS, C ;
NEUHAUSEN, S ;
CANNONALBRIGHT, L ;
GOLDGAR, D ;
WISEMAN, R ;
KAMB, A ;
SKOLNICK, MH .
SCIENCE, 1994, 266 (5182) :66-71
[24]   Brca1 controls homology-directed DNA repair [J].
Moynahan, ME ;
Chiu, JW ;
Koller, BH ;
Jasin, M .
MOLECULAR CELL, 1999, 4 (04) :511-518
[25]   Breast cancer genetics: What we know and what we need [J].
Nathanson, KN ;
Wooster, R ;
Weber, BL .
NATURE MEDICINE, 2001, 7 (05) :552-556
[26]  
Nüesch JPF, 1998, J VIROL, V72, P9966
[27]   IMPAIRED S-PHASE TRANSIT OF WERNER SYNDROME CELLS EXPRESSED IN LYMPHOBLASTOID CELL-LINES [J].
POOT, M ;
HOEHN, H ;
RUNGER, TM ;
MARTIN, GM .
EXPERIMENTAL CELL RESEARCH, 1992, 202 (02) :267-273
[28]   Cytoplasmic mislocalization of BRCA1 caused by cancer-associated mutations in the BRCT domain [J].
Rodriguez, JA ;
Au, WWY ;
Henderson, BR .
EXPERIMENTAL CELL RESEARCH, 2004, 293 (01) :14-21
[29]   Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains [J].
Rodriguez, M ;
Yu, XC ;
Chen, JJ ;
Songyang, Z .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (52) :52914-52918
[30]   BRCA1 is a cell cycle-regulated nuclear phosphoprotein [J].
Ruffner, H ;
Verma, IM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (14) :7138-7143